The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase
Open accessAbstract
BACKGROUND: There is growing awareness that tumour cells build up a "self-advantageous" microenvironment that reduces effectiveness of anti-tumour immune response. While many different immunosuppressive mechanisms are likely to come into play, recent evidence suggests that extracellular adenosine acting at A2A receptors may have a major role in down-modulating the immune response as cancerous tissues contain elevated levels of adenosine and adenosine break-down products. While there is no doubt that all cells possess plasma membrane adenosine transporters that mediate adenosine uptake and may also allow its release, it is now clear that most of extracellularly-generated adenosine originates from the catabolism of extracellular ATP. METHODOLOGY/PRINCIPAL FINDINGS: Measurement of extracellular ATP is generally performed in cell supernatants by HPLC or soluble luciferin-luciferase assay, thus it generally turns out to be laborious and inaccurate. We have engineered a chimeric plasma membrane-targeted luciferase that allows in vivo real-time imaging of extracellular ATP. With this novel probe we have measured the ATP concentration within the tumour microenvironment of several experimentally-induced tumours. CONCLUSIONS/SIGNIFICANCE: Our results show that ATP in the tumour interstitium is in the hundreds micromolar range, while it is basically undetectable in healthy tissues. Here we show that a chimeric plasma membrane-targeted luciferase allows in vivo detection of high extracellular ATP concentration at tumour sites. On the contrary, tumour-free tissues show undetectable extracellular ATP levels. Extracellular ATP may be crucial for the tumour not only as a stimulus for growth but also as a source of an immunosuppressive agent such as adenosine. Our approach offers a new tool for the investigation of the biochemical composition of tumour milieu and for development of novel therapies based on the modulation of extracellular purine-based signalling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Conversely, in a disease state as infection or brain disease, extracellular ATP levels largely increase and activate P2X7 receptors [68–70].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D. J., Usheva, A., Erat, A., Chen, J., Enjyoji, K., Linden, J. M., Oukka, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062512 · Cited by 2,613
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C. R., Poppleton, H., Koçak, M., Hogg, T. L., Fuller, C. E., Hamner, J. B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,253
A cytokine-mediated link between innate immunity, inflammation, and cancer
Lin, W.-W., & Karin, M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31537 · Cited by 1,940
A2A adenosine receptor protects tumors from antitumor T cells
Ohta, A., Gorelik, E., Prasad, S. J., Ronchese, F., Lukashev, D. E., Wong, M. K. K., Huang, X., Caldwell, S. A., Liu, K., Smith, P. T., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605251103 · Cited by 1,095
The tumour microenvironment as a target for chemoprevention
Albini, A., & Sporn, M. B. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2067 · Cited by 828
Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells
Gallina, G., Dolcetti, L., Serafini, P., Santo, C. D., Marigo, I., Colombo, M. P., Basso, G., Brombacher, F., Borrello, I., Zanovello, P., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28828 · Cited by 807
Adenosine, an endogenous distress signal, modulates tissue damage and repair
Fredholm, B. B. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402132 · Cited by 704
Sitkovsky, M. V., Lukashev, D. E., Apasov, S. G., Kojima, H., Koshiba, M., Caldwell, C. C., Ohta, A., & Thiel, M. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104731 · Cited by 697
ATP is a mediator of chemosensory transduction in the central nervous system
Gourine, A. V., Llaudet, E., Dale, N., & Spyer, K. M. (2005) · Nature · doi:10.1038/nature03690 · Cited by 537
Context, tissue plasticity, and cancer
Bissell, M. J., & LaBarge, M. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.12.013 · Cited by 517
Flagged first, then by citations
1 of the 28 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 670
Communication shapes sensory response in multicellular networks
Potter, G. D., Byrd, T. A., Mugler, A., & Sun, B. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605559113 · Cited by 20
Breast tumor‐targeted drug delivery via polymer nanocarriers: Endogenous and exogenous strategies
Zhu, M., Wang, X., Zhou, Y., Li, M., Wang, Y., Wang, Y., Li, T., Song, Y., Zhang, B., Hezam, K., et al. (2023) · Journal of Applied Polymer Science · doi:10.1002/app.54227 · Cited by 20
Hocking, K. M., Luo, W., Li, F. D., Komalavilas, P., Brophy, C. M., & Cheung‐Flynn, J. (2015) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.12.059 · Cited by 19
Role of Infiltrating Microglia/Macrophages in Glioma
Catalano, M., D’Alessandro, G., Trettel, F., & Limatola, C. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-30651-9_14 · Cited by 19
Evaluation of P2X7 Receptor Function in Tumor Contexts Using rAAV Vector and Nanobodies (AAVnano)
Demeules, M., Scarpitta, A., Abad, C., Gondé, H., Hardet, R., Pinto-Espinoza, C., Eichhoff, A. M., Schäfer, W., Haag, F., Koch‐Nolte, F., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01699 · Cited by 23
P2Y12 Purinergic Receptor and Brain Tumors: Implications on Glioma Microenvironment
Morrone, F. B., Vargas, P., Rockenbach, L., & Scheffel, T. B. (2021) · Molecules · doi:10.3390/molecules26206146 · Cited by 19
Peters, J. A., & Djanashvili, K. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215254 · Cited by 18
Zou, Y.-T., Li, J., Chai, J.-Y., Hu, Y., Zhang, W., & Zhang, Q. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.149513 · Cited by 20
Remote System for Monitoring Animal Models With Single-Metabolite Bio-Nano-Sensors
Carrara, S., Bolomey, L., Boero, C., Cavallini, A., Meurville, E., Micheli, G. D., Jost, T. R., Proietti, M., & Grassi, F. (2012) · IEEE Sensors Journal · doi:10.1109/jsen.2012.2231670 · Cited by 18
Extracellular purines and bone homeostasis
Agrawal, A., & Jørgensen, N. R. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114425 · Cited by 18
Dias, A., de Nonohay, U., & Blessmann, G. (2012) · Arquivos rio-grandenses de medicina · Cited by 18
Bustamante, S., Gilchrist, R. B., & Richani, D. (2017) · Journal of Chromatography B · doi:10.1016/j.jchromb.2017.07.044 · Cited by 18
Al-Taei, S., Salimu, J., Spary, L. K., Clayton, A., Lester, J. F., & Tabi, Z. (2017) · OncoImmunology · doi:10.1080/2162402x.2016.1268308 · Cited by 17
Brilliant Blue FCF as an Alternative Dye for Saphenous Vein Graft Marking
Voskresensky, I. V., Wise, E. S., Hocking, K. M., Li, F. D., Osgood, M. J., Komalavilas, P., Brophy, C. M., & Cheung‐Flynn, J. (2014) · JAMA Surgery · doi:10.1001/jamasurg.2014.2029 · Cited by 17
Bacterial delivery of the anti-tumor azurin-like protein Laz to glioblastoma cells
Mansour, M., Ismail, S., & Abou‐Aisha, K. (2020) · AMB Express · doi:10.1186/s13568-020-00995-8 · Cited by 17
P2X7 is a cytotoxic receptor….maybe not: implications for cancer
Virgilio, F. D. (2020) · Purinergic Signalling · doi:10.1007/s11302-020-09735-w · Cited by 17
Zhang, J., Wang, X.-J., Wu, L.-J., Yang, L., Yang, Y.-T., Zhang, D., Hong, J., Li, X.-Y., Dong, X.-Q., Guo, X.-C., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252334 · Cited by 17
Xue, X., Liu, Y., Chen, X., Tao, B.-Y., Liu, P., Zhou, H.-W., Zhang, C., Wang, L., Jiang, Y.-K., Ding, Z.-W., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1064032 · Cited by 17
Zadran, S., Amighi, A., Otiniano, E., Wong, K., & Zadran, H. (2012) · Tumor Biology · doi:10.1007/s13277-012-0505-1 · Cited by 17
P2X3 Antagonists: Novel Therapeutics for Afferent Sensitization and Chronic Pain
Ford, A. P. D. W. (2012) · Pain Management · doi:10.2217/pmt.12.16 · Cited by 17
Potential Therapeutic Applications of P2 Receptor Antagonists: From Bench to Clinical Trials
Ferreira, N. C. D. S., Alves, L. A., & Soares‐Bezerra, R. J. (2019) · Current Drug Targets · doi:10.2174/1389450120666190213095923 · Cited by 18
Piperazine squaric acid diamides, a novel class of allosteric P2X7 receptor antagonists
Patberg, M., Isaak, A., Füsser, F. T., Zacarı́as, N. V. O., Vinnenberg, L., Schulte, J., Michetti, L., Grey, L., van der Horst, C., Hundehege, P., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113838 · Cited by 16
ATP ion channel P2X7 receptor as a regulatory molecule in the progression of colorectal cancer
Zuo, C., Xu, Y., He, P., & Zhang, W. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115877 · Cited by 16
Wang, L., Cao, L., Li, Z., Shao, Z., Chen, X., Huang, Z., He, X., Zheng, J., Liu, L.-Z., Jia, X., et al. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2300812 · Cited by 15
Nguyen, T. M. D., Klett, D., Filliatreau, L., & Combarnous, Y. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217519 · Cited by 16
Graft‐versus‐host disease reduces regulatory T ‐cell migration into the tumour tissue
Dürr, C., Follo, M., Idzko, M., Reichardt, W., & Zeiser, R. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03610.x · Cited by 16
Overexpression of NTPDase2 in gliomas promotes systemic inflammation and pulmonary injury
Braganhol, E., Zanin, R. F., Bernardi, A., Bergamin, L. S., Cappellari, A. R., Campesato, L. F., Morrone, F. B., Campos, M. M., Calixto, J. Β., Edelweiss, M. I. A., et al. (2011) · Purinergic Signalling · doi:10.1007/s11302-011-9276-1 · Cited by 16
Lotfi, R., Steppe, L., Hang, R., Rojewski, M., Massold, M., Jahrsdörfer, B., & Schrezenmeier, H. (2018) · Immunity Inflammation and Disease · doi:10.1002/iid3.236 · Cited by 16
Phosphorylated Osteopontin Secreted from Cancer Cells Induces Cancer Cell Motility
Kariya, Y., Oyama, M., Kariya, Y., & Hashimoto, Y. (2021) · Biomolecules · doi:10.3390/biom11091323 · Cited by 15
Purinergic GPCR-integrin interactions drive pancreatic cancer cell invasion
Bort, E. T., Joseph, M. D., Wang, Q., Carter, E. P., Roth, N. J., Gibson, J., Samadi, A., Kocher, H. M., Simoncelli, S., McCormick, P. J., et al. (2023) · eLife · doi:10.7554/elife.86971 · Cited by 15
Programming Affinity for Precise Tumor Recognition with Allosteric Nanosensing-Circles
Ai, L., Zuo, Q., Li, Y., Wu, S., Sima, Y., Zhang, Y., Xie, S., Zhao, Z., & Tan, W. (2023) · ACS Nano · doi:10.1021/acsnano.3c01709 · Cited by 15
Wei, Q., Zhang, Y., Sun, L., Jia, X., Huai, W., Yu, C., Wan, Z., & Han, L. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9369-0 · Cited by 15
Adenosine Receptor A2B Negatively Regulates Cell Migration in Ovarian Carcinoma Cells
Campos‐Contreras, A. D. R., González‐Gallardo, A., Díaz‐Muñoz, M., & Vázquez‐Cuevas, F. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094585 · Cited by 19
Baroja‐Mazo, A., Barberà-Cremades, M., & Pelegrı́n, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070577 · Cited by 15
Strong, A. D., & Daniels, R. L. (2017) · BMC Cancer · doi:10.1186/s12885-017-3507-y · Cited by 15
Festag, J., Thelemann, T., Schell, M., Raith, S., Michel, S., Jaschinski, F., & Klar, R. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.06.020 · Cited by 15
Increased Extracellular ATP in Plasma of Rheumatoid Arthritis Patients Activates CD8+T Cells
Tripathy, A., Padhan, P., Swain, N., Raghav, S. K., & Gupta, B. (2021) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.12.010 · Cited by 14
Extracellular CD44 lactylation impairs CD8+ T cell function in KRAS-mutant colorectal cancer
Yang, Y., Wu, Y., Guo, X., Gan, W.-J., Wu, W.-X., Shi, W.-Y., He, X., Liu, Y.-X., Wan, S., Jiang, Z., et al. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01482-3 · Cited by 14
Craddick, M., Patel, R., Lower, A., Highlander, S. K., Ackermann, M. R., & McClenahan, D. J. (2012) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2012.06.011 · Cited by 14
Sphingosine-1-Phosphate Induces ATP Release via Volume-Regulated Anion Channels in Breast Cell Lines
Furuya, K., Hirata, H., Kobayashi, T., & Sokabe, M. (2021) · Life · doi:10.3390/life11080851 · Cited by 12
Scarpellino, G., Genova, T., Quarta, E., Distasi, C., Dionisi, M., Fiorio, A., & Munaron, L. (2022) · Cancers · doi:10.3390/cancers14112743 · Cited by 14
Danger signals, inflammasomes, and the intricate intracellular lives of chlamydiae
Pettengill, M. A., Sater, A. A. A., Coutinho‐Silva, R., & Ojcius, D. M. (2016) · Biomedical Journal · doi:10.1016/j.bj.2016.07.001 · Cited by 14
The role of the P2X7 receptor in myeloid-derived suppressor cells and immunosuppression
Principi, E., & Raffaghello, L. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.02.010 · Cited by 14
Self-citationMetabolic Dialogue Shapes Immune Response in the Tumor Microenvironment
Gao, F., Shah, R., Xin, G., & Wang, R. (2025) · European Journal of Immunology · doi:10.1002/eji.202451102 · Cited by 15
da Silva, J. L. G., Viana, A. R., Passos, D. F., Krause, L. M. F., Miron, V. V., Schetinger, M. R. C., Pillat, M. M., Palma, T. V., & Leal, D. B. R. (2022) · Purinergic Signalling · doi:10.1007/s11302-022-09909-8 · Cited by 13
Evidence for Ca2+-regulated ATP release in gastrointestinal stromal tumors
Berglund, E., Berglund, D., Akçakaya, P., Ghaderi, M., Daré, E., Berggren, P., Köhler, M. G., Aspinwall, C. A., Lui, W., Zedenius, J., et al. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.03.001 · Cited by 13
Ledderose, S., Rodler, S., Eismann, L., Ledderose, G., Rudelius, M., JUNGER, W. G., & Ledderose, C. (2023) · Cancers · doi:10.3390/cancers15082321 · Cited by 13
P2Y2R has a significant correlation with Notch‑4 in patients with breast cancer
Kim, D., Jin, H., Lee, J., Son, E., Lee, G., & Kim, H. J. (2020) · Oncology Letters · doi:10.3892/ol.2020.11630 · Cited by 13
Puchałowicz, K., Tarnowski, M., Tkacz, M., Chlubek, D., Kłos, P., & Dziedziejko, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124425 · Cited by 13
Muresanu, C., Somasundaram, S. G., Vissarionov, S. V., Solis, L. F. T., Herrera, A. S., Kirkland, C. E., & Aliev, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186521 · Cited by 12
Self-assembled DNA nanodevices for intelligent biosensing
Chen, Y., Tian, R., Zhang, Y., Ding, B., & Jiang, Q. (2025) · Nanoscale Horizons · doi:10.1039/d5nh00446b · Cited by 12
Purinergic system in cancer stem cells
Núñez-Ríos, J. D., Ulrich, H., Díaz‐Muñoz, M., Lameu, C., & Vázquez‐Cuevas, F. G. (2023) · Purinergic Signalling · doi:10.1007/s11302-023-09976-5 · Cited by 17
Purinergic signaling promotes premature senescence
Volonté, D., Benson, C. J., Daugherty, S. L., Beckel, J. M., Trebak, M., & Galbiati, F. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107145 · Cited by 15
Cho, H., Huh, K. M., Shim, M. S., Cho, Y., Lee, J. Y., Lee, H. S., & Kang, H. C. (2024) · Macromolecular Bioscience · doi:10.1002/mabi.202300590 · Cited by 13
Song, J., Qian, Y., Evers, M., Nielsen, C. M., & Chen, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314770 · Cited by 13
Scherr, B. F., Reiner, M. F., Baumann, F., Höhne, K., Müller, T., Ayata, C. K., Müller–Quernheim, J., Idzko, M., & Zissel, G. (2023) · BMC Immunology · doi:10.1186/s12865-023-00546-3 · Cited by 12
Adams, S. D., Kouzani, A. Z., Tye, S. J., Bennet, K. E., & Berk, M. (2018) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/s12984-018-0349-z · Cited by 12
Horenstein, A. L., Morandi, F., Bracci, C., Pistoia, V., & Malavasi, F. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.11.007 · Cited by 12
Self-citationGuggemos, J., Fuller, S. J., Skarratt, K. K., Mayer, B., & Schneider, E. M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1352789 · Cited by 11
Gao, P., Jiang, H., Du, Y., Shu, Y., Wan, Y.-W., Yin, E., Wu, J., Liang, X.-X., Wang, S.-D., Ding, Z.-H., et al. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01585-9 · Cited by 12
The Search for New Agonists to P2X7R for Clinical Use: Tuberculosis as a Possible Target
Soares‐Bezerra, R. J., Pinho, R. T., Bisaggio, R. D. C., Benévolo-de-Andrade, T. C., & Alves, L. A. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430364 · Cited by 11
Electrochemical detection of ATP release in-vitro and in-vivo
Hellmann, A., Schundner, A., Frick, M., & Kranz, C. (2023) · Current Opinion in Electrochemistry · doi:10.1016/j.coelec.2023.101282 · Cited by 11
Molcak, H., Jiang, K., Campbell, C. J., & Matsubara, J. A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1216489 · Cited by 13
Zhou, L., Cai, E., Liu, H., Cheng, H., Ye, X., Zhu, H., & Chang, X. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166895 · Cited by 10
Characterization of AB598, a CD39 Enzymatic Inhibitory Antibody for the Treatment of Solid Tumors
Anderson, A. E., Parashar, K., Jin, K., Clor, J. L., Stagnaro, C. E., Vani, U., Singh, J., Chen, A., Guan, Y., Talukdar, P., et al. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-23-0865 · Cited by 10
Coover, R. A., Healy, T. E., Li, G., Chaney, K. E., Hennigan, R. F., Thomson, C. S., Aschbacher‐Smith, L., Jankowski, M. P., & Ratner, N. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0635-9 · Cited by 10
CD73+ Dendritic Cells in Cascading Th17 Responses of Experimental Autoimmune Uveitis-Induced Mice
Ko, M. K., Shao, H., Kaplan, H. J., & Sun, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.601272 · Cited by 11
P2Y purinergic signaling in prostate cancer: Emerging insights into pathophysiology and therapy
Khalafalla, M. G., Tran, H. N., & Khalafalla, F. G. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188732 · Cited by 10
Henningsen, M. B., McWhan, K. T., Dam, V. S., Mele, M., Hauerslev, K. R., Voss, N. C. S., Dabir, P. D., Balling, E., Pedersen, H. L., Vahl, P., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34147 · Cited by 10
Emerging roles of the P2X7 receptor in cancer pain
Wu, P., Wang, Y., Liu, Y., Liu, Y., Zhou, G., Wu, X., & Wen, Q. (2022) · Purinergic Signalling · doi:10.1007/s11302-022-09902-1 · Cited by 10
Single-metabolite Bio-Nano-Sensors and system for remote monitoring in animal models
Carrara, S., Bolomey, L., Boero, C., Cavallini, A., Meurville, E., Micheli, G. D., Jost, T. R., Proietti, M., & Grassi, F. (2011) · Proceedings of IEEE Sensors/Proceedings of IEEE Sensors ... · doi:10.1109/icsens.2011.6126962 · Cited by 10
EFFECT OF THE DIETARY SUPPLEMENT ELEVATP ON BLOOD ATP LEVEL: AN ACUTE PILOT CLINICAL STUDY
Reyes-Izquierdo, T., Nemzer, B. V., Argumedo, R., Shu, C., Huynh, L., & Pietrzkowski, Z. J. (2013) · Cited by 10
Zhang, N., Fu, S., Fu, P. P., & Xu, X. (2025) · Langmuir · doi:10.1021/acs.langmuir.4c04663 · Cited by 9
Tumor hypoxia shapes natural killer cell anticancer activities
Retamal, M. A., Salazar‐Onfray, F., González, F. E., & Tittarelli, A. (2025) · Journal of Molecular Medicine · doi:10.1007/s00109-025-02557-6 · Cited by 10
Autophagolysosomal exocytosis inverts Src kinase onto the cell surface in cancer
Delaveris, C. S., Loudermilk, R. P., Pandey, A. K., Remesh, S. G., Peters-Clarke, T. M., Ganjave, S. D., Dougherty, W., Delavan, H. M., Wang, C., Ling, J., et al. (2026) · Science · doi:10.1126/science.aec1778 · Cited by 11
Gosecka, M., & Gosecki, M. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.08.039 · Cited by 9
Kaneko, C., Tsutsui, H., Ozeki, K., Honda, M., Haraya, K., Narita, Y., Kamata‐Sakurai, M., Kikuta, J., Tabo, M., & Ishii, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-08951-1 · Cited by 9
Ryoden, Y., & Nagata, S. (2022) · BioEssays · doi:10.1002/bies.202200106 · Cited by 12
Recent Advances in Supramolecular-Macrocycle-Based Nanomaterials in Cancer Treatment
Pan, Z., Zhao, X., Li, Q., Zhang, Z., & Liu, Y. (2023) · Molecules · doi:10.3390/molecules28031241 · Cited by 9
Tew, D. J., Hebert, J. M., & Schmier, B. J. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102658 · Cited by 9
Agrawal, A., Kruse, L. S., Vangsted, A. J., Gartland, A., & Jørgensen, N. R. (2020) · Cells · doi:10.3390/cells9112341 · Cited by 9
Casulli, M. A., Taurino, I., Hashimoto, T., Carrara, S., & Hayashita, T. (2021) · ACS Applied Bio Materials · doi:10.1021/acsabm.1c00166 · Cited by 9
Inflammasome Activation by Danger Signals
Pelegrı́n, P. (2011) · Springer eBooks · doi:10.1007/978-3-0348-0148-5_7 · Cited by 9
P2Y2 Receptor Functions in Cancer: A Perspective in the Context of Colorectal Cancer
Gendron, F., Placet, M., & Arguin, G. (2017) · Advances in experimental medicine and biology · doi:10.1007/5584_2017_90 · Cited by 9
Localized PD-1 Blockade in a Mouse Model of Renal Cell Carcinoma
Pham, N. B., Abraham, N., Velankar, K. Y., Schueller, N. R., Philip, E. J., Jaber, Y., Gawalt, E. S., Fan, Y., Pal, S. K., & Meng, W. S. (2022) · Frontiers in Drug Delivery · doi:10.3389/fddev.2022.838458 · Cited by 8
Lange, P. T., & Damania, B. (2023) · mBio · doi:10.1128/mbio.03459-22 · Cited by 8
ATP‐Powered Signaling Between Artificial and Living Cells
Sethi, S., Sharma, C., & Walther, A. (2025) · Angewandte Chemie International Edition · doi:10.1002/anie.202517843 · Cited by 8
Ghiasi, S. M., Christensen, N. M., Pedersen, P. A., Skovhøj, E. Z., & Novak, I. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111109 · Cited by 8
Manouchehri, J. M., Datta, J., Marcho, L. M., Reardon, J. J., Stover, D. G., Wesolowski, R., Borate, U., Cheng, T. D., Schnell, P., Ramaswamy, B., et al. (2024) · Breast Cancer Research · doi:10.1186/s13058-024-01906-6 · Cited by 8
Discrimination of Invasive Human Skin Tumor Using an Ultrafast ATP–Proton AND-Gate Probe
Jun, Y. W., Kim, K. H., Yang, Y. J., Jung, Y., Kim, K., Kim, H., Oh, B. H., & Ahn, K. H. (2022) · ACS Sensors · doi:10.1021/acssensors.1c02712 · Cited by 8
Purinergic Regulation of Airway Inflammation
Koeppen, M., Virgilio, F. D., Clambey, E. T., & Eltzschig, H. K. (2011) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-007-1217-1_7 · Cited by 8
New intriguing roles of ATP and its receptors in promoting tumor metastasis
Adinolfi, E. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9401-4 · Cited by 8
Super LCST thermo-responsive nanoparticle assembly for ATP binding through the Hofmeister effect
Kashyap, S., & Jayakannan, M. (2015) · Journal of Materials Chemistry B · doi:10.1039/c4tb01844c · Cited by 8
Forti, K. M., Woods, L. T., Jasmer, K. J., Camden, J. M., & Weisman, G. A. (2023) · Purinergic Signalling · doi:10.1007/s11302-023-09960-z · Cited by 7
Supramolecular photothermal agents mediated by black hole hosts
Gao, J., Ding, S., Chen, L., Li, H., Geng, W.-C., Guo, D., & Yuan, Z. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102520 · Cited by 9
RNA target-independent non-canonical activation (RINCA) of Cas13 trans-nuclease activity
Liu, W., Zhu, X., Xue, Y., Wang, X., Chang, L., Wang, S., Li, L., Huang, J., Zhang, Y., Cheng, J., et al. (2025) · 中国科学通报:英文版 · doi:10.1016/j.scib.2025.07.015 · Cited by 8
Ando, T., Sakurai, K., Hoshi, M., Tezuka, H., Sakai, Y., Kato, T., & Ito, H. (2025) · Immunobiology · doi:10.1016/j.imbio.2025.153119 · Cited by 7
Genetic Variations in the P2X7 Receptor: Opportunities and Challenges for Drug Development
Cheah, J. S. Y., Skarratt, K. K., Fuller, S. J., & Balle, T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110265 · Cited by 7
The multifaceted role of extracellular ATP in sperm function: From spermatogenesis to fertilization
Cao, H., Li, L., Liu, S., Wang, Y., Liu, X., Yang, F., & Dong, W. (2023) · Theriogenology · doi:10.1016/j.theriogenology.2023.10.019 · Cited by 9
Purinergic pathways and their clinical use in the treatment of acute myeloid leukemia
Wang, H., Wei, Y., & Wang, N. (2024) · Purinergic Signalling · doi:10.1007/s11302-024-09997-8 · Cited by 7
Metadata
- Authors
- Pellegatti, P., Raffaghello, L., Bianchi, G., Piccardi, F., Pistoia, V., & Di Virgilio, F.
- Affiliations
- University of Ferrara (IT)
- Istituto Giannina Gaslini (IT)
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2008-07-09
- Volume
- 3
- Issue
- 7
- Pages
- e2599
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2440522
- OpenAlex
- W2070663123
- Cited by
- 668
- References
- 28
- Citations by year
- 2026: 31 · 2025: 40 · 2024: 29 · 2023: 62 · 2022: 51 · 2021: 58 · 2020: 66 · 2019: 42 · 2018: 37 · 2017: 34 · 2016: 33 · 2015: 25 · 2014: 36 · 2013: 28 · 2012: 40
- FWCI
- 11.40
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Funders
- Fondazione Italiana per la Lotta al Neuroblastoma
- Associazione Italiana per la Ricerca sul Cancro (GGP06070)
- Università degli Studi di Ferrara
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › bioluminescence and chemiluminescence research
- Keywords
- extracellular ATP, tumor microenvironment, in vivo imaging, adenosine, adenosine A2A receptor, immunosuppression, ATP catabolism, adenosine transporter
- MeSH terms
- Adenosine Triphosphate, Animals, Cell Membrane, Extracellular Space, Humans, Luciferases, Luminescent Measurements, Mice, Nude, Neoplasms, Cell Line, Tumor, Luminescent Agents, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review